Nobuki Hayakawa

897 total citations
33 papers, 723 citations indexed

About

Nobuki Hayakawa is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Nobuki Hayakawa has authored 33 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Nobuki Hayakawa's work include Bone health and treatments (6 papers), Thyroid Disorders and Treatments (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Nobuki Hayakawa is often cited by papers focused on Bone health and treatments (6 papers), Thyroid Disorders and Treatments (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Nobuki Hayakawa collaborates with scholars based in Japan and United States. Nobuki Hayakawa's co-authors include Mitsuyasu Itoh, Atsushi Suzuki, Naohisa Oda, Hiroaki Kakizawa, Shigeo Imamura, Yasunaga Ono, Taiya Kato, Motoko Kotake, Shonen Yoshida and Katsura Nozawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Biochemistry.

In The Last Decade

Nobuki Hayakawa

29 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuki Hayakawa Japan 13 235 218 152 146 119 33 723
Sung‐Kil Lim South Korea 13 171 0.7× 200 0.9× 326 2.1× 415 2.8× 138 1.2× 25 895
Sandra Romero‐Hidalgo Mexico 16 182 0.8× 223 1.0× 147 1.0× 182 1.2× 47 0.4× 36 813
Jie Wen China 17 154 0.7× 245 1.1× 233 1.5× 236 1.6× 75 0.6× 37 843
Takafumi Taguchi Japan 17 148 0.6× 203 0.9× 215 1.4× 105 0.7× 44 0.4× 48 750
Elisabeth Svanberg Sweden 20 575 2.4× 374 1.7× 195 1.3× 73 0.5× 35 0.3× 38 1.2k
Elettra Mancuso Italy 11 154 0.7× 213 1.0× 110 0.7× 120 0.8× 62 0.5× 25 678
R. A. Meyer United States 6 174 0.7× 212 1.0× 77 0.5× 78 0.5× 37 0.3× 7 633
Masanori Iwase Japan 17 161 0.7× 194 0.9× 261 1.7× 164 1.1× 26 0.2× 45 815
Guangda Xiang China 19 369 1.6× 432 2.0× 132 0.9× 221 1.5× 35 0.3× 46 1.1k
Ond⊘řej Šeda Czechia 21 261 1.1× 519 2.4× 252 1.7× 127 0.9× 32 0.3× 84 1.1k

Countries citing papers authored by Nobuki Hayakawa

Since Specialization
Citations

This map shows the geographic impact of Nobuki Hayakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuki Hayakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuki Hayakawa more than expected).

Fields of papers citing papers by Nobuki Hayakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuki Hayakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuki Hayakawa. The network helps show where Nobuki Hayakawa may publish in the future.

Co-authorship network of co-authors of Nobuki Hayakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuki Hayakawa. A scholar is included among the top collaborators of Nobuki Hayakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuki Hayakawa. Nobuki Hayakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shibata, Megumi, et al.. (2018). Serum sclerostin concentration reflects bone turnover and glycation in men with type 2 diabetes mellitus. SHILAP Revista de lepidopterología.
3.
Hayakawa, Nobuki & Atsushi Suzuki. (2014). [Updates on Lifestyle-Related Diseases and Bone Metabolism. Effects of therapeutic agents for lifestyle-related diseases on osteoporosis].. PubMed. 24(11). 1661–9. 1 indexed citations
4.
5.
Hayakawa, Nobuki & Atsushi Suzuki. (2013). [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].. PubMed. 23(9). 1337–44. 1 indexed citations
6.
Hibi, Yatsuka, Nobuki Hayakawa, Midori Hasegawa, et al.. (2013). Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case. Surgery Today. 45(2). 241–246. 5 indexed citations
7.
Hayakawa, Nobuki & Atsushi Suzuki. (2012). [Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture].. PubMed. 22(9). 1383–90. 9 indexed citations
8.
Suzuki, Atsushi, Hitomi Sasaki, S Asano, et al.. (2012). Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease. Journal of Bone and Mineral Metabolism. 31(1). 116–122. 11 indexed citations
9.
Itoh, Yuki, Nobuki Hayakawa, Naohisa Oda, et al.. (2011). A Case of POEMS Syndrome with Endocrinopathy.. Nihon Naika Gakkai Zasshi. 100(10). 3038–3040.
10.
Udagawa, Yasuhiro, et al.. (2008). Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.. PubMed. 14(2). CS9–12. 8 indexed citations
11.
Oda, Naohisa, Shigeo Imamura, Takashi Fujita, et al.. (2008). The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism. 57(2). 268–273. 158 indexed citations
12.
Ono, Yasunaga, Naohisa Oda, Shin Ishihara, et al.. (2008). Insulinoma cell calcium-sensing receptor influences insulin secretion in a case with concurrent familial hypocalciuric hypercalcemia and malignant metastatic insulinoma.. European Journal of Endocrinology. 159(1). 81–86. 6 indexed citations
13.
Nagasaka, Akio, Yoshikuni Sawai, Nobuki Hayakawa, et al.. (2004). Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters. Journal of Molecular and Cellular Cardiology. 37(3). 767–774. 11 indexed citations
14.
Kakizawa, Hiroaki, Mitsuyasu Itoh, Shigeo Imamura, et al.. (2004). The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism. 53(5). 550–555. 81 indexed citations
15.
Uchimura, Keiko, Akio Nagasaka, Nobuki Hayakawa, et al.. (2002). Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels. Metabolism. 51(7). 871–875. 23 indexed citations
16.
Hayakawa, Nobuki, Keiko Uchimura, Masaki Makino, et al.. (1998). Vitamin E and Coenzyme Q Concentrations in the Thyroid Tissues of Patients With Various Thyroid Disorders. The American Journal of the Medical Sciences. 315(4). 230–232. 7 indexed citations
17.
Sakamoto, Hideo, Masaki Makino, Hiroaki Kakizawa, et al.. (1998). Effects of Thyroid Hormone on Catecholamine and its Metabolite Concentrations in Rat Cardiac Muscle and Cerebral Cortex. Thyroid. 8(4). 353–358. 33 indexed citations
18.
Shinohara, Rikio, Yoshikuni Sawai, Keiko Uchimura, et al.. (1998). Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochimica et Biophysica Acta (BBA) - General Subjects. 1425(3). 577–586. 17 indexed citations
19.
Nakai, Akira, Motoko Kotake, Yoshikuni Sawai, et al.. (1997). Alteration of platelet aggregation in patients with thyroid disorders. Metabolism. 46(10). 1128–1131. 26 indexed citations
20.
Nakai, Akira, Yoshikuni Sawai, Keiji Miura, et al.. (1997). Recombinant human TSH receptor expressed in E. coli. Clinica Chimica Acta. 263(1). 15–23. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Kil Lim Breakdown of academic impact, for papers by Sandra Romero‐Hidalgo Breakdown of academic impact, for papers by Jie Wen Breakdown of academic impact, for papers by Takafumi Taguchi Breakdown of academic impact, for papers by Elisabeth Svanberg Breakdown of academic impact, for papers by Elettra Mancuso Breakdown of academic impact, for papers by R. A. Meyer Breakdown of academic impact, for papers by Masanori Iwase Breakdown of academic impact, for papers by Guangda Xiang Breakdown of academic impact, for papers by Ond⊘řej Šeda
Rankless by CCL
2026